Literature DB >> 26640527

Biological and therapeutic activities, and anticancer properties of curcumin.

Donatella Perrone1, Fatima Ardito1, Giovanni Giannatempo1, Mario Dioguardi1, Giuseppe Troiano1, Lucio Lo Russo1, Alfredo DE Lillo1, Luigi Laino1, Lorenzo Lo Muzio1.   

Abstract

Curcumin (diferuloylmethane) is a polyphenol derived from the Curcuma longa plant. Curcumin has been used extensively in Ayurvedic medicine, as it is nontoxic and exhibits a variety of therapeutic properties, including antioxidant, analgesic, anti-inflammatory and antiseptic activities. Recently, certain studies have indicated that curcumin may exert anticancer effects in a variety of biological pathways involved in mutagenesis, apoptosis, tumorigenesis, cell cycle regulation and metastasis. The present study reviewed previous studies in the literature, which support the therapeutic activity of curcumin in cancer. In addition, the present study elucidated a number of the challenges concerning the use of curcumin as an adjuvant chemotherapeutic agent. All the studies reviewed herein suggest that curcumin is able to exert anti-inflammatory, antiplatelet, antioxidative, hepatoprotective and antitumor activities, particularly against cancers of the liver, skin, pancreas, prostate, ovary, lung and head neck, as well as having a positive effect in the treatment of arthritis.

Entities:  

Keywords:  anti-inflammatory activity; anticancer agents; cancer; curcumin; nutraceutical

Year:  2015        PMID: 26640527      PMCID: PMC4665301          DOI: 10.3892/etm.2015.2749

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  103 in total

1.  RETRACTED: Increased Ras GTPase activity is regulated by miRNAs that can be attenuated by CDF treatment in pancreatic cancer cells.

Authors:  Shadan Ali; Aamir Ahmad; Amro Aboukameel; Bin Bao; Subhash Padhye; Philip A Philip; Fazlul H Sarkar
Journal:  Cancer Lett       Date:  2012-01-17       Impact factor: 8.679

Review 2.  Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation.

Authors:  Y J Surh; K S Chun; H H Cha; S S Han; Y S Keum; K K Park; S S Lee
Journal:  Mutat Res       Date:  2001-09-01       Impact factor: 2.433

3.  Curcumin protects against acute liver damage in the rat by inhibiting NF-kappaB, proinflammatory cytokines production and oxidative stress.

Authors:  Karina Reyes-Gordillo; José Segovia; Mineko Shibayama; Paula Vergara; Mario G Moreno; Pablo Muriel
Journal:  Biochim Biophys Acta       Date:  2007-02-22

4.  Curcumin downregulates the inflammatory cytokines CXCL1 and -2 in breast cancer cells via NFkappaB.

Authors:  Beatrice E Bachmeier; Isabelle V Mohrenz; Valentina Mirisola; Erwin Schleicher; Francesco Romeo; Clara Höhneke; Marianne Jochum; Andreas G Nerlich; Ulrich Pfeffer
Journal:  Carcinogenesis       Date:  2007-11-13       Impact factor: 4.944

5.  Adjuvant chemoprevention of experimental cancer: catechin and dietary turmeric in forestomach and oral cancer models.

Authors:  M A Azuine; S V Bhide
Journal:  J Ethnopharmacol       Date:  1994-12       Impact factor: 4.360

6.  Antitumor action of curcumin in human papillomavirus associated cells involves downregulation of viral oncogenes, prevention of NFkB and AP-1 translocation, and modulation of apoptosis.

Authors:  Chandrasekhar S Divya; M Radhakrishna Pillai
Journal:  Mol Carcinog       Date:  2006-05       Impact factor: 4.784

7.  Demethoxycurcumin from Curcuma longa rhizome suppresses iNOS induction in an in vitro inflamed human intestinal mucosa model.

Authors:  Mayura Somchit; Chatchawan Changtam; Rungruedi Kimseng; Tanyarath Utaipan; Monthon Lertcanawanichakul; Apichart Suksamrarn; Warangkana Chunglok
Journal:  Asian Pac J Cancer Prev       Date:  2014

8.  Comparative effects of curcumin and an analogue of curcumin in carbon tetrachloride-induced hepatotoxicity in rats.

Authors:  Narasimhanaidu Kamalakkannan; Rajagopalan Rukkumani; Penumathsa Suresh Varma; Periyasamy Viswanathan; Kallikat Narayanan Rajasekharan; Venugopal Padmanabhan Menon
Journal:  Basic Clin Pharmacol Toxicol       Date:  2005-07       Impact factor: 4.080

Review 9.  Curcumin differs from tetrahydrocurcumin for molecular targets, signaling pathways and cellular responses.

Authors:  Bharat B Aggarwal; Lokesh Deb; Sahdeo Prasad
Journal:  Molecules       Date:  2014-12-24       Impact factor: 4.411

10.  Curcumin-conjugated nanoliposomes with high affinity for Aβ deposits: possible applications to Alzheimer disease.

Authors:  Adina N Lazar; Spyridon Mourtas; Ihsen Youssef; Christophe Parizot; Aurélien Dauphin; Benoît Delatour; Sophia G Antimisiaris; Charles Duyckaerts
Journal:  Nanomedicine       Date:  2012-12-07       Impact factor: 5.307

View more
  61 in total

Review 1.  Nanodelivery systems and stabilized solid-drug nanoparticles for orally administered medicine: current landscape.

Authors:  Ali Kermanizadeh; Leagh G Powell; Vicki Stone; Peter Møller
Journal:  Int J Nanomedicine       Date:  2018-11-16

2.  Combined effects of curcumin and doxorubicin on cell death and cell migration of SH-SY5Y human neuroblastoma cells.

Authors:  Jirapat Namkaew; Thiranut Jaroonwitchawan; Narawadee Rujanapun; Jantip Saelee; Parinya Noisa
Journal:  In Vitro Cell Dev Biol Anim       Date:  2018-08-22       Impact factor: 2.416

Review 3.  Protective Effects of Curcumin Against Ischemia-Reperfusion Injury in the Nervous System.

Authors:  Kowsar Bavarsad; George E Barreto; Mousa-Al-Reza Hadjzadeh; Amirhossein Sahebkar
Journal:  Mol Neurobiol       Date:  2018-06-09       Impact factor: 5.590

4.  Curcumin suppresses epithelial-to-mesenchymal transition and metastasis of pancreatic cancer cells by inhibiting cancer-associated fibroblasts.

Authors:  Qing Wang; Chao Qu; Fang Xie; Lianyu Chen; Luming Liu; Xiaohua Liang; Xueyong Wu; Peng Wang; Zhiqiang Meng
Journal:  Am J Cancer Res       Date:  2017-01-01       Impact factor: 6.166

5.  Cytotoxic, chemosensitizing and radiosensitizing effects of curcumin based on thioredoxin system inhibition in breast cancer cells: 2D vs. 3D cell culture system.

Authors:  Shaymaa Essam El Feky; Magda Abdel Ghany Megahed; Nadia Ahmed Abd El Moneim; Ebtsam Rizq Zaher; Shadwa Ahmed Khamis; Lamiaa Mohamed Ahmed Ali
Journal:  Exp Ther Med       Date:  2021-03-18       Impact factor: 2.447

6.  Curcumin Ameliorates Heat-Induced Injury through NADPH Oxidase-Dependent Redox Signaling and Mitochondrial Preservation in C2C12 Myoblasts and Mouse Skeletal Muscle.

Authors:  Tianzheng Yu; Jacob Dohl; Li Wang; Yifan Chen; Heath G Gasier; Patricia A Deuster
Journal:  J Nutr       Date:  2020-09-01       Impact factor: 4.798

7.  Curcumin directly inhibits the transport activity of GLUT1.

Authors:  Leesha K Gunnink; Ola D Alabi; Benjamin D Kuiper; Stephen M Gunnink; Sam J Schuiteman; Lauren E Strohbehn; Kathryn E Hamilton; Kathryn E Wrobel; Larry L Louters
Journal:  Biochimie       Date:  2016-03-31       Impact factor: 4.079

8.  Protective effect of curcumin on lead acetate-induced testicular toxicity in Wistar rats.

Authors:  Sri Agus Sudjarwo; Giftania Wardani Sudjarwo
Journal:  Res Pharm Sci       Date:  2017-10

9.  Resveratrol (3,5,4'-trihydroxystilbene) and its properties in oral diseases.

Authors:  Donatella Perrone; Maria Pia Fuggetta; Fatima Ardito; Andrea Cottarelli; Anna De Filippis; Giampietro Ravagnan; Salvatore De Maria; Lorenzo Lo Muzio
Journal:  Exp Ther Med       Date:  2017-05-18       Impact factor: 2.447

10.  The Effects of Curcumin on Diabetes Mellitus: A Systematic Review.

Authors:  Ledyane Taynara Marton; Laís Maria Pescinini-E-Salzedas; Maria Eduarda Côrtes Camargo; Sandra M Barbalho; Jesselina F Dos Santos Haber; Renata Vargas Sinatora; Claudia Rucco Penteado Detregiachi; Raul J S Girio; Daniela Vieira Buchaim; Patricia Cincotto Dos Santos Bueno
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-03       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.